Journal of Vascular and Interventional Radiology最新文献

{"title":"Transarterial Radioembolization for Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria: A Single-Center Retrospective Cohort Study.","authors":"Tae Wook Baek, Gun Ha Kim, Eunbyeol Ko, Jeongyeon Kim, Changhwan Sung, Hyo Jung Park, Sehee Kim, Hee Ho Chu, Jin Hyoung Kim, Dong Il Gwon","doi":"10.1016/j.jvir.2026.109108","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.109108","url":null,"abstract":"<p><strong>Purpose: </strong>To describe clinical outcomes after transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) beyond the Up-to-Seven criteria.</p><p><strong>Materials and methods: </strong>This retrospective study included 94 treatment-naïve patients with HCC beyond the Up-to-Seven criteria who underwent TARE between November 2021 and December 2025. Outcomes included tumor response, local tumor progression-free survival (LTPFS), progression-free survival (PFS), overall survival (OS), and adverse events.</p><p><strong>Results: </strong>The median maximum tumor diameter was 9.5 cm (interquartile range, 7.1-11.4 cm). A single lesion was observed in 55 (58.5%) patients, 30 (31.9%) had oligonodular disease, and 9 (9.6%) had ≥5 lesions. Index-lesion complete response (CR) and objective response rate (ORR) were 38.3% and 83.0%, respectively; at the patient level, CR and ORR were 38.3% and 81.9%, respectively. Median index-lesion LTPFS, patient-level LTPFS, PFS, and OS were 19.6, 15.7, 11.1, and 30.5 months, respectively. Low tumor-absorbed dose (TAD) was independently associated with worse OS (adjusted hazard ratio, 2.70; p = 0.016). Twenty-one patients (22.3%) subsequently underwent curative-intent surgery after TARE, with a more favorable OS pattern observed in the postsurgery state in an exploratory time-varying analysis (p = 0.004). Three fatal adverse events occurred.</p><p><strong>Conclusion: </strong>In this single-center retrospective cohort of patients with HCC beyond the Up-to-Seven criteria, favorable tumor control and survival outcomes were observed after TARE, and 22.3% of patients subsequently underwent curative-intent surgery. Higher TAD was associated with longer OS, although this finding should be interpreted cautiously given the potential for confounding. Careful dosimetric planning is warranted given the observed fatal radiation pneumonitis events.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109108"},"PeriodicalIF":3.1,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149117361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Twenty-Three-Year Single Center Experience with Elective Transcatheter Coil Embolization of Unruptured Splenic Artery Aneurysms.","authors":"Ariana C Mills, Rico Pesce, Rahul Patel, Edward Kim, Aaron Fischman, Rajesh Patel, Vivian Bishay, Kirema Garcia-Reyes, Dan Shilo, Jenanan Vairavamurthy, Brett Marinelli, Ageliki Vouyouka, Rami Tadros, Peter Faries, Scott Nowakowski, Michael Marin, Robert Lookstein","doi":"10.1016/j.jvir.2026.109111","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.109111","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the safety and efficacy of elective coil embolization for unruptured splenic artery aneurysms (SAA).</p><p><strong>Materials and methods: </strong>A retrospective review of unruptured SAA treated endovascularly from October 2002 to January 2026 was performed. When the inflow vessel was embolized, primary technical success required both cessation of antegrade flow in the inflow vessel and absence of opacification of the aneurysm sac. When the sac alone was embolized or excluded, primary technical success required absence of sac opacification alone. Risk factors for major splenic infarct were assessed.</p><p><strong>Results: </strong>A total of 156 unique aneurysms were treated in 130 patients. Mean aneurysm size was 2.4 ± 1.1 cm. Primary technical success was achieved in all but one (0.8%) patient over a mean follow-up of 4.1 ± 5.0 years. Secondary technical success was 100% and freedom from sac opacification was 95.1%. Reintervention was required in 4/122 (3.3%) patients with follow-up imaging, all of whom remained successfully treated. Major splenic infarct occurred in 17/122 (13.9%) patients, with portal hypertension as the only independent risk factor for major splenic infarct (adjusted OR 6.07; 95% CI 1.90-19.35; p = 0.002). Eight (6.2%) mortalities occurred, one (0.8%) within 30 days, all unrelated to SAA embolization.</p><p><strong>Conclusion: </strong>Elective coil embolization is a safe and effective treatment for SAA with robust rates of technical success, freedom from rupture, and freedom from sac enlargement.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109111"},"PeriodicalIF":3.1,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149117625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Within-Patient Association between Improvement in Lower Urinary Tract Symptoms and Change in Sexual Function after Prostatic Artery Embolization.","authors":"Tamim Kawakibi, Fatoumata Barry, Griffin J P McNamara, Justin P McWilliams","doi":"10.1016/j.jvir.2026.108974","DOIUrl":"10.1016/j.jvir.2026.108974","url":null,"abstract":"<p><p>This single-center retrospective study examined whether urinary symptom improvement after patients after prostatic artery embolization (PAE) for lower urinary tract symptoms secondary to benign prostatic hyperplasia was associated with erectile or ejaculatory function change. Urinary symptoms severity (International Prostate Symptom Score [IPSS]), erectile function (Sexual Health Inventory for Men [SHIM]), and ejaculatory function (Male Sexual Health Questionnaire-Ejaculatory Dysfunction [MSHQ-EjD]) were assessed at baseline and at 3 and 12 months in 183 patients. Mean IPSS improved by 12.0 points. After adjustment for age, baseline score, medications, and comorbidities, greater IPSS improvement was associated with greater SHIM improvement at the first (partial r = -0.17; P = .025) and second (partial r = -0.25; P = .020) follow-up, strengthening in the baseline erectile dysfunction subgroup (partial r = -0.38; P = .008). Within that subgroup, strong urinary responders more often achieved the SHIM minimal clinically important difference (26.3% vs 3.8%; P = .014). No association was found with ejaculatory function.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108974"},"PeriodicalIF":3.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148563718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contralateral Suppression Indices and the Need for Outcome-Based Reference Standards in Primary Aldosteronism.","authors":"Gian Paolo Rossi, Federico Bernardo Rossi, Michele Battistel, Giulio Barbiero, Filippo Crimì","doi":"10.1016/j.jvir.2026.108950","DOIUrl":"10.1016/j.jvir.2026.108950","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108950"},"PeriodicalIF":3.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mechanical Thrombectomy for Acute Ischemic Stroke Performed at High-Volume Institutions Results in Better Patient Outcomes.","authors":"Renate Ma, Omar Ashraf, Carol Kittel, Ashley M Aguillard, Kyle M Fargen, Stacey Q Wolfe","doi":"10.1016/j.jvir.2026.108975","DOIUrl":"10.1016/j.jvir.2026.108975","url":null,"abstract":"<p><strong>Purpose: </strong>To examine the relationship between patient outcomes and mechanical thrombectomy (MT) volumes since the implementation of extended time window thrombectomies.</p><p><strong>Materials and methods: </strong>Data were obtained from the National Inpatient Sample (NIS) maintained by the Agency for Healthcare Research and Quality. The annual volumes of MT were collected at the institutional level during 2017-2021 using the International Classification of Diseases, 10th Revision, Clinical Modification, codes. For the statistical analysis, a multivariate logistic regression analysis was used to analyze the effect of MT volume on mortality while controlling for the following: race, age, case complication, institution bed size, institution region, and institutional location/teaching status.</p><p><strong>Results: </strong>There were 27,797 MT cases identified in the NIS during 2017-2021, which corresponds to a national estimate of 138,985 total cases during this timeframe. Case volumes increased every year from 2017 to 2021. Over this time period, there was a 1.2% reduction in odds of mortality per every 10 MT case increase (odds ratio, 0.988; 95% CI, 0.980-0.995; P = .001. The total complication rate in this series of patients was 71.7%, with 40.5% of all patients having cardiac complications and 30.5% of all patients having pulmonary complications.</p><p><strong>Conclusions: </strong>Improved MT outcomes continue to be observed at high-volume institutions despite the implementation of the extended time window for thrombectomy, although cardiac and pulmonary complications constitute a significant source of morbidity and may represent an opportunity to improve outcomes at low-volume centers.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108975"},"PeriodicalIF":3.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148563559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Infections after Prostatic Artery Embolization for Benign Prostatic Hyperplasia: An Analysis of the Published Evidence.","authors":"Stelios-Elion Bousi, Konstantinos M Katsikas, Maria Tsitskari, Matthew E Falagas","doi":"10.1016/j.jvir.2026.109103","DOIUrl":"10.1016/j.jvir.2026.109103","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the hypothesis that infectious adverse events following prostatic artery embolization (PAE) are comparable to those following other treatment options for benign prostatic hyperplasia (BPH).</p><p><strong>Materials and methods: </strong>A literature review was conducted from database inception through August 2025 to identify studies reporting infectious outcomes, including urinary tract infection (UTI), prostatitis, and urosepsis, after PAE for BPH. Both comparative and noncomparative studies, including randomized controlled trials (RCTs) and prospective and retrospective observational designs, were included.</p><p><strong>Results: </strong>Thirty-nine studies met the eligibility criteria: 5 RCTs, 14 prospective cohorts, and 20 retrospective cohorts. Among comparative studies, the median reported UTI percentages were 3.7% (interquartile range [IQR], 1.9%-5%), ranging from 0% to 27.5%, across 1,722 patients and 4.8% (IQR 2.7%-27.4%), ranging from 1.6% to 36.5%, across 11,393 patients who underwent PAE and transurethral resection of the prostate (TURP), respectively. In prospective noncomparative cohorts, the median reported UTI percentage was 3.5% (IQR, 1.7%-6.9%), ranging from 1% to 13.3% across the 1,172 included patients. Among retrospective noncomparative cohorts, the median reported UTI percentage was 3% (IQR, 1.6%-4.3%), ranging from 0.3% to 11.8% across the 5,752 included patients. Six noncomparative studies reported infectious adverse events in patients with indwelling catheters. The median reported percentage of infectious adverse events was 5.5% (IQR, 2.6%-11.5%), ranging from 1% to 12.7% among the 379 included patients. Specific data on prostatitis and urosepsis were infrequently reported as adverse events across the included studies.</p><p><strong>Conclusions: </strong>Infectious adverse events following PAE appear comparable to those observed after comparator procedures such as TURP. Higher infection percentages were observed in subgroups of patients with indwelling catheters.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109103"},"PeriodicalIF":3.1,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149117116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in Glycemic Parameters After Celiac Plexus Neurolysis in Patients with Type 2 Diabetes Mellitus: A Retrospective Case Series.","authors":"Tushar Garg, Melissa Putman, Leo L Tsai, David Hao, Raul Uppot, Ashraf Thabet, Shams Iqbal, Thomas J An","doi":"10.1016/j.jvir.2026.109104","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.109104","url":null,"abstract":"<p><p>Celiac plexus neurolysis (CPN) ablates the celiac ganglia using dehydrated (99%) ethanol, typically for palliation of upper abdominal pain. The sympathetic nervous system contributes to hepatic glucose production and suppression of insulin secretion, so disruption of these pathways may alter glycemic regulation. Glycemic outcomes are described in 6 patients with Type 2 diabetes mellitus who underwent CPN for chronic abdominal pain over a 9-year period. All 6 procedures were technically successful without 30-day adverse events, and no hypoglycemic episodes occurred during follow-up. At 6 and 12 months, all 6 patients showed reductions in HbA1c (mean change: -1.3% and -1.1%, respectively) and fasting glucose (mean change: -44.0 mg/dL and -52.2 mg/dL, respectively). Of the 4 insulin-treated patients, 2 discontinued insulin entirely and 2 had their insulin dose reduced. These hypothesis-generating findings suggest CPN may have an incidental effect on glycemic control warranting prospective evaluation.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109104"},"PeriodicalIF":3.1,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149117725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anorectal Pain in Patients with Pelvic Floor Dysfunction and Central Pelvic Sensitization Following Hemorrhoidal Embolization.","authors":"Nicholas Xiao, Forrest B Linch, Adam Nygard, Scott M Thompson","doi":"10.1016/j.jvir.2026.109101","DOIUrl":"10.1016/j.jvir.2026.109101","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109101"},"PeriodicalIF":3.1,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149065032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Procedural and Functional Outcomes After Computer Assisted Vacuum Thrombectomy With the 16F Catheter System for Treatment of Pulmonary Embolism: A Subanalysis of the STRIKE-PE Study.","authors":"John M Moriarty, Brian J Schiro, Ido Weinberg, Suhail Y Dohad, Hugh C Davis, David M Shavelle, George S Chrysant, Paul E Perkowski, Patrick E Muck, Vivian L Bishay, Andrew Holden, Frances M West, Matthew J Scheidt, Sanjum S Sethi, W Brent Keeling, Aleksander Araszkiewicz","doi":"10.1016/j.jvir.2026.109100","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.109100","url":null,"abstract":"<p><strong>Purpose: </strong>This subanalysis of the STRIKE-PE study evaluates use of computer assisted vacuum thrombectomy (CAVT), a form of endovascular therapy for acute pulmonary embolism (PE), with the 16F catheter system.</p><p><strong>Materials and methods: </strong>This subanalysis from a prespecified interim analysis reports procedural outcomes and functional outcomes to 90 days from the first 244 patients treated using the 16F catheter system in STRIKE-PE, an ongoing single-arm, prospective, global study evaluating safety, effectiveness, and outcomes after CAVT in patients with acute PE. The primary end points of STRIKE-PE are change in right-to-left ventricular (RV/LV) ratio from baseline to 48-hour follow-up and composite major adverse event (MAE) rate within 48 hours.</p><p><strong>Results: </strong>Mean RV/LV ratio at baseline was 1.34, which decreased to 0.95 at 48 hours postprocedure (27.3% reduction; P < .001). The composite MAE rate within 48 hours was 0.8%. Procedural results included a reduction in mean on-table systolic pulmonary artery pressure (23.6% reduction; P < .001) and a median thrombectomy time of 25 minutes. The functional outcome assessments of Borg dyspnea scale (P < .001) and 6-minute walk test distance (P < .001) progressively improved to 90 days. New York Heart Association (NYHA) class I or none increased from 67.4% of patients at discharge to 82.9% at 90-day follow-up (P < .001).</p><p><strong>Conclusions: </strong>Treatment of PE with CAVT using the 16F catheter system was associated with statistically significant improvement in right heart function, hemodynamics, dyspnea, and distance walked; additionally, NYHA class recovered. The device had a short procedure time and a low composite MAE rate.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109100"},"PeriodicalIF":3.1,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149065093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From Distance Measurement to Anatomic Landmark: The Cranial Tributary-based Flush Ablation Protocol for Anatomic Landmark-Guided Catheter Tip Positioning in Great Saphenous Vein Ablation.","authors":"Binshan Zha, Long Wang, Xianyu Hu, Xuefeng Tian, Yifan Fan, Zhe Zhang, Xu Zhang, Zhiyong Chen","doi":"10.1016/j.jvir.2026.109098","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.109098","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the feasibility, safety, and mid-term outcomes of the Cranial Tributary-based Flush Ablation (CTFA) protocol, using the first effective cranial tributary (FECT) as the primary landmark for catheter tip positioning (CTP).</p><p><strong>Materials and methods: </strong>Consecutive patients undergoing radiofrequency (RFA) or microwave ablation (MWA) with the CTFA protocol between June 2023 and March 2024 were retrospectively included. Under transverse ultrasound, the catheter was retracted until the FECT orifice (>5 mm distal to the saphenofemoral junction) disappeared; predefined distance-based positioning served as fallback; all received pharmacological thromboprophylaxis. Primary endpoints were technical success, FECT-guided applicability, endothermal heat-induced thrombosis (EHIT) 2-4, and anterior accessory saphenous vein (AASV) recurrence. RFA and MWA were compared by propensity score matching in the 97-limb follow-up cohort; random forest-based imputation and Kaplan-Meier analysis addressed missing data.</p><p><strong>Results: </strong>Technical success was 100% (159/159). FECT-guided applicability was 80.5% (128/159; Scenario 1: 11.3% [18/159], Scenario 2: 69.2% [110/159]); 31 limbs (19.5%, Scenario 3) required the distance-based fallback. Mean CTP distance was 15.7 mm. EHIT-2 occurred in 1.3% (2/159), with no EHIT-3/4. At 18 months, duplex follow-up was available for 97/159 limbs (61%); crude AASV recurrence was 8.2% (8/97), with a Kaplan-Meier recurrence-free survival of 93.40%. Great saphenous vein occlusion was 100%, 98.6%, and 95.9% at 1 week, 6 months, and 18 months. Stump-length evolution (biphasic) and clinical outcomes were comparable between modalities.</p><p><strong>Conclusion: </strong>Using the FECT as the primary landmark, the CTFA protocol demonstrated feasibility and acceptable mid-term safety; whether it improves procedural consistency requires prospective validation.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"109098"},"PeriodicalIF":3.1,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149065013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}